Liquidia Corporation (LQDA)
$27.38-2.28%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV46.4%–238.7%
- Market cap
- $2.4B
- Beta
- 0.54
- P/E (TTM)
- 16.51
- IV-%ile
- 89
- IV ATM
- 150.7%
- Short % float
- 20.28%
- Days to cover
- 3.8
- SI change
- +2.1%
- 1W
- -4.40%
- 1M
- -59.65%
- vs SPY 1W
- -5.56%
- vs SPY 1M
- -62.64%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on LQDA?
- LOPJLB’s latest quantitative signal on Liquidia Corporation (LQDA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LQDA in?
- Liquidia Corporation (LQDA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Liquidia Corporation (LQDA) do?
- Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hyper…